Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sanmiao Powder is a Traditional Chinese Medicine (TCM) herbal formula composed of three primary ingredients: *Phellodendri Chinensis Cortex* (Huang Bai), *Atractylodis Rhizoma* (Cang Zhu), and *Achyranthis Bidentatae Radix* (Niu Xi). It is an expansion of the Ermiao Powder formula, specifically designed to address 'damp-heat' syndromes in TCM theory. In modern clinical practice, it is primarily utilized for the treatment of gouty arthritis, rheumatoid arthritis, and inflammatory conditions of the lower limbs. The formula exerts its therapeutic effects through multi-target mechanisms, including the inhibition of pro-inflammatory cytokines such as interleukin-1 beta (IL-1β) and tumor necrosis factor (TNF), and the potential regulation of uric acid metabolism. The Guangdong Provincial Hospital of Chinese Medicine has conducted mechanistic studies using chinmedomics to identify the material basis and pharmacodynamic pathways of this formula in patients with damp-heat gouty arthritis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sanmiao powder.